Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
DNA topoisomerase I (TOP1) |
Target Info
|
Inhibitor |
[2], [3] |
| References |
Top |
| REF 1 |
ClinicalTrials.gov (NCT00005869) Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer. U.S. National Institutes of Health.
|
| REF 2 |
Rubitecan. Expert Opin Investig Drugs. 2006 Jan;15(1):71-9.
|
| REF 3 |
A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors. Cancer. 2003 Jan 1;97(1):148-54.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
